ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 91 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,785,711 | +62.1% | 267,322 | +103.6% | 0.01% | +66.7% |
Q2 2023 | $1,101,607 | -49.7% | 131,300 | -40.5% | 0.00% | -50.0% |
Q1 2023 | $2,189,565 | -30.2% | 220,500 | -51.1% | 0.01% | -40.0% |
Q4 2022 | $3,136,782 | +1.0% | 450,687 | -22.5% | 0.01% | -9.1% |
Q3 2022 | $3,105,000 | +28.4% | 581,439 | -4.1% | 0.01% | +37.5% |
Q2 2022 | $2,418,000 | +58.7% | 606,068 | +76.8% | 0.01% | +100.0% |
Q1 2022 | $1,524,000 | -43.7% | 342,887 | -49.4% | 0.00% | -33.3% |
Q4 2021 | $2,708,000 | -61.3% | 677,072 | -15.0% | 0.01% | -62.5% |
Q3 2021 | $6,991,000 | -45.4% | 796,225 | -29.6% | 0.02% | -44.8% |
Q2 2021 | $12,811,000 | +22.3% | 1,130,734 | +28.2% | 0.03% | +7.4% |
Q1 2021 | $10,478,000 | +129.2% | 881,962 | +32.4% | 0.03% | +107.7% |
Q4 2020 | $4,571,000 | -7.9% | 666,369 | -0.5% | 0.01% | -27.8% |
Q3 2020 | $4,963,000 | +585.5% | 669,834 | +285.6% | 0.02% | +350.0% |
Q2 2020 | $724,000 | +273.2% | 173,733 | +121.1% | 0.00% | +100.0% |
Q1 2020 | $194,000 | -65.7% | 78,560 | +91.9% | 0.00% | 0.0% |
Q3 2018 | $565,000 | – | 40,929 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |